Post-autologous transplant maintenance therapies in lymphoma: current state and future directions
Sign Up to like & getrecommendations! Published in 2018 at "Bone Marrow Transplantation"
DOI: 10.1038/bmt.2017.196
Abstract: Disease relapse following high-dose chemotherapy and autologous stem cell transplant (ASCT) remains the principal cause of mortality in patients with relapsed or refractory lymphomas. In an effort to prevent post-ASCT relapse, a number of studies… read more here.
Keywords: lymphoma; transplant maintenance; maintenance; post asct ... See more keywords